← Open Payments lookup

PAUL DAVIS: Open Payments

NPI 1386637221 · WHITE HALL, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$399 in 21 payments from 9 companies in 2025. Trend: 2023 $823 · 2024 $317 · 2025 $399

Food & beverage: $399
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$109
ABBVIE INC.4$77
Novo Nordisk Inc3$53
GlaxoSmithKline, LLC.3$51
Lundbeck LLC2$38
Merck Sharp & Dohme LLC1$22
Amgen Inc.1$19
AngioDynamics, Inc.1$15
Lilly USA, LLC1$15

Products named: CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, REXULTI, UBRELVY, GARDASIL 9, OTEZLA, AURYON LASER SYSTEM 100-120 VAC.

Industry payments across AR — which companies pay providers there.